GILD News 100.99 09/16/2014 04:55:58 Gilead Sciences (GILD)

New Post Public Reply Private Reply Replies (0) Message Board
Stock_Tracker
Gilead Sciences (GILD) 100.99 $GILD

'Fast Money' Recap: How Alibaba Is Hitting Momentum Stocks
at The Street - 55 mins ago
The trading panel discussed Chinese stocks, Apple's new phone and whether Darden shares are worth buying.

NPS Pharmaceuticals' Natpara Gets Positive FDA Panel Vote - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Mon Sep 15, 6:05PM CDT
The EMDAC of the FDA recommended the approval of NPS Pharmaceuticals' Natpara.

Alnylam Expands Pipeline with Preeclampsia Drug ALN-AGT - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Mon Sep 15, 6:00PM CDT
Alnylam (ALNY) expanded its pipeline with ALN-AGT a subcutaneously administrated RNAi therapeutic that targets AGT.

Gilead to license Sovaldi
at Investor's Business Daily - Mon Sep 15, 5:53PM CDT
The big-cap biotech is licensing its megasuccessful hepatitis C drug Sovaldi to Indian generic-drug makers such as Ranbaxy Labs and Cipla, in addition to U.S.-based Mylan (MYL). One course of the Gilead Sciences (GILD) treatment is currently $84,000...

Final Glance: Biotechnology companies
AP - Mon Sep 15, 5:03PM CDT
NEW YORK (AP) — Shares of some top biotechnology companies were mixed at the close of trading:

Biogen/AbbVie Report Positive Data on MS Drug Zinbryta - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Mon Sep 15, 4:50PM CDT
Biogen Idec Inc. (BIIB) and partner AbbVie Inc. (ABBV) announced detailed positive results from the phase III study on Zinbryta.

Novartis Presents Positive Data on Lucentis and Jetrea - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Mon Sep 15, 4:35PM CDT
Novartis (NVS) presented encouraging data on Lucentis and Jetrea at the EURETINA congress in London.

Abbott Labs Presents Positive One-Year Data on Absorb - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Mon Sep 15, 4:20PM CDT
Abbott Laboratories (ABT) announced positive one-year results from the randomized, controlled trial ABSORB II, on its drug-eluting coronary bioresorbable vascular scaffold (BVS) Absorb.

Amarin Plunges after the FDA Denies Vascepa SPA Appeal - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Mon Sep 15, 3:45PM CDT
Amarin Corporation (AMRN) announced that the FDA's Office of New Drugs denied the company's appeal regarding the rescission of the Special Protocol Assessment covering the phase III ANCHOR study on Vascepa.

Look for Shares of Gilead Sciences to Potentially Rebound after Yesterday's 2.58% Sell Off
Comtex SmarTrend(R) - Mon Sep 15, 3:39PM CDT
Gilead Sciences (NASDAQ:GILD) traded in a range yesterday that spanned from a low of $99.33 to a high of $102.10. Yesterday, the shares fell 2.6%, which took the trading range below the 3-day low of $102.89 on volume of 18.1 million shares. Often times after large one-day declines, short-term traders may play for some degree of mean reversion.

SmarTrend Watching for Potential Rebound in Shares of Gilead Sciences After 2.58% Loss
Comtex SmarTrend(R) - Mon Sep 15, 3:38PM CDT
Gilead Sciences (NASDAQ:GILD) traded in a range yesterday that spanned from a low of $99.33 to a high of $102.10. Yesterday, the shares fell 2.6%, which took the trading range below the 3-day low of $102.89 on volume of 18.1 million shares. Often times after large one-day declines, short-term traders may play for some degree of mean reversion.

Alere and Avanir are big market movers
AP - Mon Sep 15, 3:33PM CDT
NEW YORK (AP) — Stocks that moved substantially or traded heavily Monday on the New York Stock Exchange and the Nasdaq Stock Market:

Eli Lilly's Cyramza Scores in Colorectal Cancer Study - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Mon Sep 15, 3:30PM CDT
Eli Lilly and Company (LLY) announced that Cyramza met the primary endpoint in a phase III study (RAISE) conducted in patients suffering from metastatic colorectal cancer.

Genomic Health Reveals Positive Oncotype DX Test Results - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Mon Sep 15, 2:00PM CDT
Currently, Genomic Health (GHDX) is focused on boosting its Oncotype DX portfolio in the international market

Midday Glance: Biotechnology companies
AP - Mon Sep 15, 12:24PM CDT
NEW YORK (AP) — Shares of some top biotechnology companies are down at 1 p.m.:

3 Reasons McKesson Corporation's Stock Could Rise
Keith Speights, The Motley Fool - Motley Fool - Mon Sep 15, 12:00PM CDT
Biotechs aren't the only hot healthcare stocks. Just look at pharmaceutical distributor and healthcare technology giant McKesson Corporation . It's up around 20% so far this year and has more than doubled over the last couple of years. Can these...

Jim Cramer Answers Twitter (TWTR) Questions on Alibaba IPO, Yahoo! (YHOO), Apple (AAPL) and More
at The Street - Mon Sep 15, 11:47AM CDT
TheStreet's Jim Cramer answers Twitter (TWTR) questions from the floor of the New York Stock Exchange, and he first tackles the upcoming Alibaba IPO.

Video: Gilead OKs Generic Sovaldi To Expand Access
at Investor's Business Daily - Mon Sep 15, 10:35AM CDT
Big-cap biotech and IBD 50 stock Gilead Sciences (GILD) said Monday that it's licensing its megablockbuster hepatitis C drug Sovaldi to seven Indian generic-drug companies to improve access in 91 developing countries. Gilead's stock fell about 2% on...

Why Is Gilead Sciences, Inc. Stock Offering This Drug for Cheap?
Todd Campbell, The Motley Fool - Motley Fool - Mon Sep 15, 10:25AM CDT
Gilead Sciences' Sovaldi has been a game changing therapy for thousands of patients in America and Europe, but patients living in poverty stricken countries in Africa and Asia have been shut out from the drug, which costs $84,000 for 12 weeks of...

Early Glance: Biotechnology companies
AP - Mon Sep 15, 9:37AM CDT
NEW YORK (AP) — Shares of some top biotechnology companies are down at 10 a.m.:
Scroll down for more posts ▼

Top 10 Most Recent News Articles

Volta M100 Puts Flexibility at Pad Printing's Center

Updated Category News Views 18

A tabletop printer rarely earns a second glance, but the Volta M100 is making a sensible argument: small manufacturers do not need another rigid box that becomes obsolete the minute a job changes. Boston Industrial Solutions has introduced the Volta M100 as a pad-printing machine built around adjustability, operator convenience, and software that can be upgraded as...

Continue Reading
Vusion Lands a 2,000-Store dm EdgeSense Rollout in Germany

Updated Category News Views 135

A drugstore shelf rarely gets anyone's pulse racing, but 2,000 of them wired into a live digital system is a serious retail deployment. Vusion has expanded its partnership with dm-drogerie markt to roll out its newest EdgeSense platform across about 2,000 German stores over the next three years. This is not a glossy one-store pilot with a ribbon-cutting and a few tablets...

Continue Reading
Boat Market Forecast Puts Services in the Driver’s Seat

Updated Category News Views 37

A jet ski is not exactly a sober economic indicator, yet the water is telling a useful story. MarketsandMarkets projects the global recreational boat market will rise from $31.38 billion in 2026 to $48.06 billion in 2033, a 6.3% compound annual growth rate. That is respectable growth for a costly discretionary category that got knocked around by softer purchasing activity...

Continue Reading
Stand Takes Colorado Bet on Wildfire-Smart Coverage

Updated Category News Views 164

Colorado’s insurance mess has finally attracted a company willing to price the driveway, the vents, and the tree line instead of shrugging at an entire ZIP code. Stand has launched homeowners coverage across the state, including mountain communities where wildfire exposure has made insurance both costly and scarce. This is not a small problem dressed up with a shiny...

Continue Reading
Medical School Rejections Carry a Steep Price Tag Too

Updated Category News Views 107

A rejection letter can turn into a remarkably expensive piece of paper. BeMo Academic Consulting's new Medical School Admissions Trends Report argues that the damage from missing medical-school admission goes far beyond bruised confidence: applicants can spend thousands chasing another cycle, lose time entering practice, and, if they never get in, forgo what the report...

Continue Reading
TRUSTA Targets AI Inference's GPU Memory Squeeze Hard

Updated Category News Views 87

GPU scarcity has turned ordinary server parts into strategic assets, and TRUSTA is leaning right into that uncomfortable fact at SuperComputing 2026. The enterprise-storage brand under ADATA is pitching an upgraded AI Scaler Toolkit built around a fairly sensible premise: companies running large-language-model inference should not have to buy another armful of expensive...

Continue Reading
Envision and Tai Tam Put 45 MW Wind Bet to Work in Vietnam

Updated Category News Views 104

A wind site averaging 6.5 meters per second can look unremarkable on a map, yet that is precisely where equipment choices start separating serious developers from brochure merchants. Envision Energy and Vietnam's Tai Tam Group are taking that test on with the 45 MW Phuoc Dan wind project in Khanh Hoa Province. The arrangement follows five years of cooperation, but the...

Continue Reading
Makers Nutrition Credit Puts a Clock on New Brands

Updated Category News Views 222

A few cents per bottle can look downright beautiful when a new supplement brand is staring at its first production bill. Makers Nutrition announced on November 17 a Black Friday manufacturing-credit offer aimed at entrepreneurs and established sellers launching a new formulation, with qualifying new orders eligible for as much as $0.45 per unit through November 29, 2026....

Continue Reading
Insider Risk Makes Human Judgment a Security Priority

Updated Category News Views 46

A badge, a password, and a locked gate can all look reassuring right up until the person holding them starts to crack. Signpost Six's new report, The Psychology of Insider Risk, lands on an uncomfortable truth: the most consequential security weakness may not be a system at all. It may be an employee under strain, in conflict, in debt, making a mistake, or being quietly...

Continue Reading
ASUS Brings AI Infrastructure Choices to SC26 Floor

Updated Category News Views 257

Compute buyers are sick of being handed one locked box That is the nerve ASUS is pressing at SC26: enterprises want AI infrastructure that fits the job in front of them, not somebody else's tidy product roadmap. The company is pitching a full-stack “AI Factory” blueprint built across Intel, AMD and NVIDIA hardware, running from rack-scale systems and conventional...

Continue Reading

Top 5 Most Recently Viewed Articles

TRUBAR Inc. Takes Bold Steps with Personal Care Product Sale

Updated Category News Views 169

TRUBAR Inc. Streamlines Focus with Recent Asset Sale TRUBAR Inc. is making significant moves to streamline its operations and focus on its core identity as a leading provider of plant-based protein products. The company has announced that it has successfully sold the assets related to its personal care product line through its subsidiary, NO BS Life, LLC. This strategic...

Continue Reading
Advancements in Squamous Cell Carcinoma Treatments Unveiled

Updated Category News Views 362

Examining Treatments for Squamous Cell Carcinoma The landscape of squamous cell carcinoma (SCC) treatments is rapidly evolving. This shift is largely driven by the increasing number of diagnosed cases. As public awareness rises and exposure to risk factors like ultraviolet (UV) radiation continues, healthcare professionals and researchers are persistently seeking...

Continue Reading
Millennium Physician Group and IMA Medical Group Unite for Better Care

Updated Category News Views 327

Millennium Physician Group and IMA Medical Group Unite for Better Patient Care In an exciting development for healthcare in Central Florida, Millennium Physician Group has announced its collaboration with IMA Medical Group. This partnership represents a major step forward in expanding value-based, patient-centered care to the local communities. About the New Partnership...

Continue Reading
Innovative Partnership to Revolutionize Osteoporosis Detection

Updated Category News Views 96

Strategic Alliance to Enhance Osteoporosis Awareness Naitive Technologies Ltd., a leader in population health innovation focused on musculoskeletal care, has embarked on an important partnership with Parvizi Surgical Innovation (PSI). This collaboration aims to significantly improve the detection and clinical management of osteoporosis, particularly through the use of...

Continue Reading
Storm and Fire Survivors Unite at U.S. Capitol for Aid

Updated Category News Views 451

Storm and Fire Survivors Unite at U.S. Capitol for Aid Recently, over fifty storm and fire survivors convened at the U.S. Capitol to advocate for robust disaster relief and a more effective recovery system for affected families and communities, in an event organized by Organizing Resilience. These brave individuals came together to share their compelling stories,...

Continue Reading